deals · US Edition
Animab Series B 2025
Animab Series B 2025
Type
funding
Amount
EUR 10M
Date
2025-01-01T00:00:00.000Z
Round
series-b
TLDR
Animab raised EUR 10M in a Series B round in 2025 to advance its animal health antibody platform.
Overview
Animab raised EUR 10M in a Series B in 2025. The company develops antibody-based treatments for animal health, applying monoclonal antibody technology to veterinary medicine. The Series B capital supports further pipeline development and potential commercialization efforts.
See also
Team memberAnimab
Filed under